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Abstract
Introduction
Next-generation sequencing is revo-
lutionising the study of genetic varia-
tion and its role in disease. Individual 
DNA samples can now be sequenced 
cost-effectively enabling analysis of 
the complete spectrum of genetic vari-
ation. This technology has the poten-
tial to contribute significantly to the 
understanding of non- syndromic 
cleft lip and/or palate. This condi-
tion occurs with relatively high fre-
quency and only a proportion of the 
underlying genetic causal factors have 
been identified. Many of the genes 
implicated have been found through 
genome-wide association studies but 
further progress is limited because 
these approaches consider only com-
mon genetic variants and neglect rarer 
variations. Because many of the causal 
genetic variants remain unknown, the 
role of gene-environment and gene-
gene interaction is difficult to charac-
terise. The identification of novel, low 
frequency, variants will provide new 
insights into the biological mecha-
nisms and pathways involved in the 
condition. Sequence-based analysis 
will also be invaluable for fine mapping 
causal variants in the larger regions 
already identified by linkage and asso-
ciation studies for which positive iden-
tification of causal genetic variants has 
proven difficult. This review considers 
the available evidence for the genes 
involved and current understand-
ing of how genetic variation interacts 
with environmental factors known to 
influence risk. Only by characterising 
the underlying genetic factors will the 
effort to understand gene-environ-
ment interaction and underlying func-
tional processes be successful.
Conclusion 
Success with next-generation 
sequencing will lead to improvements 
in prediction, prevention, and treat-
ment for cleft lip and palate patients.
Introduction
Next-generation sequencing (NGS) 
is revolutionising genomics1 and 
this trend of increasingly significant 
impact is likely to continue. Most 
importantly, NGS provides a route 
to characterising and understand-
ing the role of genetic variation in 
disease. This is important because 
evidence from genome-wide asso-
ciation studies (GWAS) suggests that 
much of the heritability underlying 
complex disease phenotypes is not 
explained by common deleterious 
genetic variants with small effect 
sizes2. NGS enables new analytical 
strategies, which are not achievable 
through genome-wide association 
studies. These include: the identifi-
cation of the complete complement 
of DNA variants in samples (across 
the allele frequency  spectrum); tests 
on the burden of rare variation(do 
 specific genes contain many rare var-
iants which collectively impair gene 
 function?); the identification of de 
novo mutations and the genes under-
lying rare Mendelian forms of dis-
ease; fine mapping of causal variants 
within broader regions identified by 
linkage and/or association and the 
characterisation of important struc-
tural variation, such as differences in 
copy number, which may contribute 
to disease.
Orofacial cleft lip and/or palate 
(CLP) represents a complex pheno-
type for which NGS offers the potential 
to increase understanding. CLP phe-
notypes are among the most frequent 
birth defects with rates of between 
1/500 and 1/2500 births3. The fre-
quency of CLP phenotypes is related 
to population ancestry, geographical 
location, maternal age, prenatal expo-
sures and socioeconomic status4–6. 
The frequency of orofacial clefting 
(OC) is higher in Latin American and 
Asian countries7. CLP phenotypes 
are classified into syndromic and 
non-syndromic forms. The former 
includes many conditions which have 
simple Mendelian modes of inherit-
ance in families for which a number 
of causal genes have already been 
identified through, for example, link-
age mapping. However, ~70% of CLP 
cases occur as isolated phenotypes 
without any additional cognitive or 
craniofacial structural abnormalities. 
These are usually described as iso-
lated non-syndromic cleft lip and/or 
palate (NSCLP). Understanding the 
factors underlying NSCLP phenotypes 
is important to improve prevention, 
treatment and prognosis of the condi-
tion. However, the genetic dissection 
of NSCLP phenotypes is challenging 
and progress towards understand-
ing the underlying genetic and envi-
ronmental factors, and how they are 
inter-related, has, until recently, been 
relatively slow, despite decades of 
research. This review considers the 
impact of recent work and, in particu-
lar, prospects for progress through 
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the application of NGS to further char-
acterise underlying genetic variation 
and its role in NSCLP.
Genetic factors and NSCLP 
NSCLP is a genetically complex dis-
order8 which results from interac-
tions between multiple genetic and 
environmental risk factors. The dis-
order has a significant genetic basis 
and it is known that first degree rela-
tives of affected individuals have a 
30–40 fold increased risk compared 
to the background population3,9. The 
degree of phenotype concordance for 
monozygotic (MZ) twins is 40–60% 
compared to 5% for di-zygotic twins. 
Murray10 and Grosen et al.11 found 
heritability estimates exceeding 90% 
for CLP phenotypes. Genetic stud-
ies including linkage analysis12,13, 
genome-wide association, and GWAS-
based meta-analysis14, have yielded 
reproducible evidence for several 
genes and gene regions8. Results from 
Ludwig et al.14 identified four genes 
and gene regions (IRF6, 8q24, 17q22 
and 10q25; Table 1) for which the 
total population attributable risk is 
~55% suggesting that, unusually for 
a complex trait, a substantial propor-
tion of the variation in NSCLP might 
be explained by these loci15. However, 
many uncertainties remain. Poor 
concordance between regions iden-
tified by linkage with those found by 
association mapping (Table 1) must 
reflect in part the different targets 
of the techniques. Association map-
ping is good for detecting common 
variants contributing small effect 
sizes in population samples whereas 
linkage mapping is more powerful 
where there is allelic heterogeneity, 
for example where multiple (rare) 
variants in a particular gene contrib-
ute to disease. But, although many of 
these signals have been replicated in 
independent samples, several of the 
linkage regions are broad and the 
underlying causal gene(s) are poorly 
established. Incomplete knowledge 
about gene function presents diffi-
culties for selecting the most likely 
Table 1 Some genes and gene regions implicated in non-syndromic cleŌ  lip 
and/or palate
Nearest or 
causal gene
Region Protein funcƟ on Method Reference
PAX7 1p36 TranscripƟ on factor: neural 
crest development in 
mouse
AssociaƟ on 14
ARHGAP29 1p22 RegulaƟ on of binding 
proteins involved in 
craniofacial development
AssociaƟ on 14
IRF6 1q32 Involved in formaƟ on of 
connecƟ ve Ɵ ssue
AssociaƟ on/
linkage
12–14
THADA 2p21 Possible regulatory 
funcƟ ons
AssociaƟ on 14
TGFA 2p13 Involved in signalling 
pathway for cell 
proliferaƟ on, diﬀ erenƟ aƟ on 
and development
Linkage 12
EPHA3 3p11 RegulaƟ on of cell shape 
and cell:cell contacts
AssociaƟ on 14
- 8q21 Intergenic region AssociaƟ on 14
- 8q24 Gene desert: may contain 
regulatory elements for 
craniofacial development
AssociaƟ on 14
FOXE1 9q21 TranscripƟ on factor 
regulaƟ ng diverse 
developmental processes
Linkage 12, 13 
VAX1 10q25 TranscripƟ onal regulator AssociaƟ on 14
SPRY2 13q31 Signal is inter-genic, nearest 
gene is regulator of mulƟ ple 
receptor tyrosine kinases
AssociaƟ on 14
PAX9,TGFB3, 
BMP4
14q
22-24
BMP4: bone 
morphogeneƟ c protein 
involved in bone/carƟ lage 
development
Linkage 12, 13 
TPM1 15q22 Signal is inter-genic, in 
regulatory region, gene 
encodes acƟ n-binding 
protein
AssociaƟ on 14
FOXC2, 
CRISPLD2
16q24 FOXC2: transcripƟ on 
factor, possible role 
in development of 
mesenchymal Ɵ ssues
Linkage 12, 13 
NOG 17q22 EssenƟ al for carƟ lage 
morphogenesis and joint 
formaƟ on
AssociaƟ on 14 
MAFB 20q12 TranscripƟ on factor 
involved in development of 
keraƟ nocytes
AssociaƟ on 14
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candidate gene(s) in these regions. 
Several gene regions identified by 
linkage in earlier studies12 have not 
replicated subsequently in independ-
ent samples13. Successful replication 
is difficult to achieve and it is per-
haps too early to dismiss some of the 
more uncertain signals. Association 
mapping frequently reveals variants 
in inter-genic regions which are sug-
gested to have regulatory functions 
influencing gene(s) nearby. Such 
a mechanism has only been firmly 
established for a small number of 
regions and identifying the precise 
causal variant(s) is made more diffi-
cult because of extensive linkage dis-
equilibrium. It is particularly difficult 
to understand the precise functional 
roles of these apparent regulatory 
variants. Frequently, the nearest gene 
and/or gene with the most plausible 
NSCLP-related function is highlighted 
(Table 1). Other issues which have 
not been resolved by linkage and 
association studies include causes of 
apparent differences in the underly-
ing genetic basis of NSCLP between 
populations of different ethnicity. One 
region which has been extensively 
studied is 8q24 for which Murray 
et al.16 found much stronger evi-
dence in European-derived samples, 
compared to Asians. In this case, the 
 difference was attributed to reduced 
haplotype diversity in the Asian sam-
ple reducing power, rather than a dis-
tinct genetic effect. It is far from clear 
that such a mechanism accounts for 
ethnic genetic differences in other 
candidate gene regions.
Although understanding of the 
genetic basis of NSCLP phenotypes 
has advanced considerably in recent 
years, many unanswered questions 
remain, for which NGS may offer a 
route to progress. NGS has the poten-
tial to identify novel genes and other 
sources of causal variation (such as 
differences in copy number) which 
contribute to NSCLP. Furthermore, 
because sequencing can identify 
most DNA variants (rather than com-
mon ‘tag’ single-nucleotide poly-
morphisms, as in GWAS), it has the 
potential to help determine actual 
causal variants rather than assign-
ments to a broader region. The 
sequencing of many NSCLP genomes 
will be essential to establish models 
which consider the roles of regulatory 
sequences and the genes involved.
Environmental factors and gene-
environment interaction 
Although high MZ concordance is con-
sistent with substantial genetic influ-
ences, the incomplete concordance 
suggests non-genetic influences on 
NSCLP phenotypes. Environmental 
effects might generate incomplete 
penetrance through random develop-
mental events or a non-homogeneous 
in utero environment10. Grosen et al.11 
pointed out that MZ twin discordance 
might reflect genetic, cytogenetic or 
epigenetic anomalies in the affected 
twin that are not found in the unaf-
fected twin. Post-zygotic genomic 
alterations resulting from mitotic 
recombination have been considered 
but have been shown by Kimani et al.17 
to not be a common cause of MZ twin 
discordance in CLP. Their analysis did 
not exclude rare or balanced genomic 
alterations, tissue-specific events 
and small aberrations beyond the 
resolution of their methods (~1Mb). 
Sequence-level resolution achieved 
by NGS might be informative given 
appropriately designed studies.
Establishing relationships 
between genetic and environmental 
factors has proven extremely chal-
lenging so far. Skare et al.9 conducted 
a large study aimed at detecting inter-
actions between 334 candidate genes 
and maternal first trimester expo-
sure to smoking, alcohol, coffee, folic 
acid supplements, dietary folate and 
vitamin A. This study contrasted 425 
case-parent triads with 562 control-
parent triads. Very little evidence for 
gene-environment interaction was 
found in these data. They noted that 
‘it is remarkable that OC, a phenotype 
of supposedly very high heritability, 
remains so hard to decipher’. The 
authors consider that larger sample 
sizes and, therefore, greater power 
to establish effects are required. 
Butali et al.18 examined interactions 
between the MTHFR gene C677T var-
iant and folic acid in OC aetiology19. 
They contrasted 1149 isolated cases 
and 1161controls and considered 
maternal peri-conceptional exposure 
to smoking, alcohol and folic acid. 
Although folic acid and smoking were 
found to influence OC outcomes, no 
significant interaction was demon-
strated with the C677T variant. Beaty 
et al.20 found some evidence for gene-
environment interaction using availa-
ble data on maternal smoking during 
pregnancy in European case-parent 
trios. The genes involved were GRID2 
and ELAVL2. However, neither gene 
showed evidence of association with 
NSCLP in the absence of the smoking 
interaction effect.
Efforts have been made to under-
stand the underlying molecular 
mechanisms behind NSCLP and their 
relationship to genetic and environ-
mental factors. Studies contrasting 
the transcriptome of dental pulp 
stem cells from NSCLP patients with 
controls suggest that there are altera-
tions in gene networks ( differentially 
expressed genes) functionally rel-
evant to orofacial development, such 
as collagen metabolism and extracel-
lular matrix remodelling21. Because 
NSCLP is considered to arise through 
 anomalies in cellular migration, pro-
liferation, trans-differentiation and 
apoptosis21,22 Kobayahi et al.23 con-
sidered possible overlap between 
NSCLP and cancer gene pathways. 
They demonstrated that NSCLP 
patient-derived stem cells show dys-
regulation in gene networks con-
trolling cellular defences against 
DNA damage. The authors speculate 
that alterations in a small number 
of upstream genetic or epigenetic 
regulators, combined with deleteri-
ous genetic variants could disrupt the 
modulating activity of transcription 
factors such as E2F1. Hence genetic 
and epigenetic variation underlying 
regulatory anomalies, combined with 
environmental factors, may be driv-
ing NSCLP. Continuing progress with 
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this functional work is hampered, 
in part, by incomplete understand-
ing of underlying genetic  factors. 
Specifically, it is not clear that the 
small number of NSCLP variants 
identified thus far can account for 
the dys-regulation of cellular func-
tions and pathways identified and 
none of the differentially expressed 
genes identified correspond to the 
known GWAS variants23. To inves-
tigate how regulatory anomalies 
underlie the development of NSCLP, 
it is necessary to characterise the 
complete spectrum of variation in 
genome sequences, including all 
regulatory variants in non-coding 
regions24.
NGS: some practical 
considerations
Although NGS has enjoyed dramatic 
success through the identifica-
tion of genes underlying Mendelian 
disorders25, and also de novo disease 
mutations26, complex phenotypes 
such as NSCLP have proven much 
more difficult to elucidate. Aside from 
numerous data quality control, tech-
nical and data management issues, a 
particular difficulty arises from the 
many, often apparently deleterious 
DNA variants, identified in each DNA 
sample. Faced with this complexity, 
various  methods to ‘filter’ variants 
lists are undertaken to try to exclude 
‘neutral’ variation. This procedure 
involves removal of ‘common’ variants 
(those represented in high frequency 
in databases of sequence variants 
from individuals lacking recognised 
disease) and removal of implausible 
disease candidates in genes which are 
highly mutable27. Such genes include 
those with sensory or immune func-
tions for which high allele diversity is 
adaptive. Frequently, it is cost-effective 
to sequence only the protein coding 
exons of genes (the ‘exome’), repre-
senting only 1% of the genome. From 
an exome sequence, non- synonymous 
variants (those that change an amino 
acid in the protein) can be selected 
for further study and other variants 
excluded. A disadvantage of using 
only the exome and extensive filtering 
is that variants in non- coding regions, 
which may have regulatory functions, 
along with much of the structural 
variants, are excluded. Even a highly 
filtered list of non- synonymous vari-
ants may contain many potentially 
deleterious variants, which do not in 
fact influence the phenotype. Various 
predictive metrics such as SIFT and 
PolyPhen2 have been developed 
which help discriminate potentially 
deleterious variants from those that 
are neutral. SIFT predicts whether an 
amino acid substitution affects pro-
tein function based on conservation of 
amino acid residues across  species28. 
PolyPhen2 considers impacts of 
an amino acid substitution on the 
structure and function of a protein29. 
Low scores (~0) for SIFT and high 
scores (~1) for PolyPhen2 suggest 
that the variant may be deleterious 
and contribute to disease. Figure 1 
presents SIFT and PolyPhen2 scores 
for non-synonymous variants in the 
IRF6gene, which contains variants 
involved in both syndromic forms 
of CLP (Van der Woude(VDW) and 
popliteal pterygium syndrome30 and 
NSCLP (Table 1). Scores for variants 
in this gene from the Exome Variant 
Server (EVS: a database of 6400 
exome sequences)31 and known dis-
ease causal variants from the Human 
Gene Mutation Database (HGMD)32,33 
are shown. The score for an exome-
sequenced patient from Colombia 
with typical popliteal pterygium syn-
drome, who has the rs121434226 
single-nucleotide polymorphism in 
IRF6, is also given. Although there is a 
degree of separation between known 
neutral and known causal variations 
(and the Colombian patient score is 
clearly deleterious by both measures), 
there is also overlap. These functional 
predictive methods can be useful for 
ranking variants worthy of further 
investigation but are not fully dis-
criminatory, particularly for complex 
phenotypes where individual variants 
have reduced penetrance.
Figure 1: Polyphen2 and SIFT scores of variants in the IRF6 gene. PolyPhen-2 
versus SIFT scores for non-synonymous variants in the IRF6 gene. Presumed 
neutral variants from the Exome Variant Server (EVS, n = 12), variants 
reported to cause CLP from the Human Gene Mutation Database (HGMD, 
n = 80) and the aetiological SNP from an exome sequenced in our Colombian 
patient (Col) are shown. Variants known to cause CLP are clearly clustered 
in the bottom right of the plot, representing a predicted deleterious nature 
by both metrics.
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0.75
0.50
0.25
0.00
0.00 0.25 0.50 0.75 1.00
S
IF
T
PolyPhen-2
Source
Col
EVS
HGMD
Page 5 of 6
Critical review
Co
m
pe
Ɵ n
g 
in
te
re
st
s:
 n
on
e 
de
cl
ar
ed
. C
on
fl i
ct
 o
f i
nt
er
es
ts
: n
on
e 
de
cl
ar
ed
.
A
ll 
au
th
or
s 
co
nt
rib
ut
ed
 to
 th
e 
co
nc
ep
Ɵ o
n,
 d
es
ig
n,
 a
nd
 p
re
pa
ra
Ɵ o
n 
of
 th
e 
m
an
us
cr
ip
t,
 a
s 
w
el
l a
s 
re
ad
 a
nd
 a
pp
ro
ve
d 
th
e 
fi n
al
 m
an
us
cr
ip
t.
A
ll 
au
th
or
s 
ab
id
e 
by
 th
e 
A
ss
oc
ia
Ɵ o
n 
fo
r M
ed
ic
al
 E
th
ic
s 
(A
M
E)
 e
th
ic
al
 ru
le
s 
of
 d
is
cl
os
ur
e.
Licensee OA Publishing London 2013. Creative Commons Attribution Licence (CC-BY)
FĔė ĈĎęĆęĎĔē ĕĚėĕĔĘĊĘ: Collins A, Arias L, Pengelly R, Martínez J, Briceño I, Ennis S. The potential for next-generation 
sequencing to characterise the genetic variation underlying non-syndromic cleft lip and palate phenotypes. 
OA  Genetics 2013 Sep 01;1(1):10.
Discussion 
The identification of genetic fac-
tors underlying NSCLP has proven 
extremely challenging although 
recent progress with GWAS, and 
subsequent meta-analyses, have 
firmly implicated a number of genes 
and variants in NSCLP phenotypes. 
Although multiple loci identified 
through GWAS appear capable of 
explaining a relatively high propor-
tion of the heritability low concord-
ance between linkage and association 
studies strongly suggests that rarer 
variations, which can be detected by 
NGS, will provide additional causal 
insights. NGS sequencing studies 
will be invaluable for fine mapping 
causal variants in linkage and GWAS-
identified genes and in pursuing 
additional, rarer, variations in related 
genes and pathways, along with novel 
genes. Only by developing a greater 
understanding of the underlying 
genetic basis of NSCLP will efforts 
to understand gene-environment 
interaction and functional processes 
underlying NSCLP be successful.
NGS also has the potential to con-
tribute to understanding of the roles 
of different genetic factors amongst 
different ethnic groups and how these 
interact with diverse environmen-
tal influences. NGS is also capable of 
delimiting distinct disease sub-types 
within the NSCLP ‘umbrella’ which is 
important for refining diagnosis and 
tailoring treatment. The development 
of integrated models which consider 
gene-gene and gene-environment 
interaction and how these influence 
the function of key pathways will 
underpin more complete understand-
ing. Although exome sequencing is 
valuable, whole genome sequencing 
of many individuals from different 
populations, comprehensive phe-
notyping, and careful consideration 
of environmental factors, may be 
required for establishing regulatory 
roles of some variants. However, NGS 
presents considerable challenges 
for data analysis and interpreta-
tion. Much effort is now focussed on 
addressing these difficulties and, as 
many more genomes are sequenced, 
further success in understanding the 
role of genes in NSCLP phenotypes is 
expected.
Conclusion
Although important recent advances 
have revealed some of the genetic 
variants underlying NSCLP, NGS has 
the potential to identify novel genetic 
factors. Only given more compre-
hensive understanding of genetic 
 variation underlying NSCLP can inter-
actions between genes, and between 
genes and environmental variables, 
be firmly identified. Success with NGS 
will lead to improvements in predic-
tion, prevention and treatment for 
cleft lip and palate patients.
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